More Company News

MaxCyte

Q122 results
09 May 2022Read More

MaxCyte

CFO departure and preliminary Q122 revenue
13 Apr 2022Read More

MaxCyte

Q421 and FY21 financial results
22 Mar 2022Read More

MaxCyte

Cenk Sumen named Chief Scientific Officer
10 Mar 2022Read More

MaxCyte

SPL with Intima Bioscience
01 Feb 2022Read More

MaxCyte

Preliminary unaudited Q4 & FY21 revenue results
24 Jan 2022Read More

MaxCyte

Q321 results
10 Nov 2021Read More

MaxCyte

Strategic Platform Licence signed with Nkarta Inc
28 Oct 2021Read More

MaxCyte

Q2 and H121 results and preliminary FY21 revenue guidance
13 Sep 2021Read More

MaxCyte

Clinical and commercial licence with Sana Biotechnology
09 Aug 2021Read More

1 2 3 4 … 9
Return to MaxCyte
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).